The pain patch market has seen considerable growth due to a variety of factors.
•The market landscape for pain patches has seen significant expansion in the past few years. The market, which was worth $4.24 billion in 2024, is projected to increase to $4.48 billion in 2025, representing a compound annual growth rate (CAGR) of 5.7%.
Factors contributing to this growth during the historical period include a rising preference for non-invasive methods for managing pain, a higher number of road accidents, an uptick in chronic illnesses, increased instances of post-operative pain, and a greater prevalence of trauma and injuries.
The pain patch market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the pain patch market size is set to witness robust growth. The market is projected to reach a valuation of $5.82 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%.
This growth during the projected period can be credited to the rising adoption of opioids for pain control, an increase in demand for targeted pain alleviation without significant systemic side effects, alterations in lifestyle, a surge in office-related professions, and a growing need for convenient and user-friendly effective alternatives. The key trends during this period are expected to be innovative solutions, the inclusion of sophisticated drug delivery technologies, partnerships amongst leading players, technological progressions, and strategic alliances.
A surge in pain disorders is anticipated to fuel the expansion of the pain patch industry. These disorders are characterized by pain as the key symptom, resulting from psychological stress, inflammation diseases, and bodily injuries. Pain patches manage these disorders by administering drugs directly into the bloodstream via the skin, ensuring a sustained and balanced release of medication over a considerable duration. An example is the Scottish Health Survey 2022 released in December 2023 by the Scottish Government, indicating that in 2022, above a third (38%) of Scottish adults experienced persistent pain or discomfort for three months or longer. The rate was higher in women (43%) as compared to men (33%). Thus, the increase in pain disorders is set to spur the development of the pain patch industry.
The pain patch market covered in this report is segmented –
1) By Type: Opioid, Non-Opioid
2) By Route Of Administration: Metered Dose, Microneedle Patches
3) By Therapeutic Use: Pain Relief, Anesthesia, Smoking Cessation, Cough Suppression, Diarrhea Suppression
4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies
Subsegments:
1) By Opioid: Fentanyl Patches, Buprenorphine Patches, Other Opioid Patches
2) By Non-Opioid: Lidocaine Patches, Capsaicin Patches, Diclofenac Patches, Other Non-Opioid Patches
A key trend becoming more prominent in the pain patch market is the progression of groundbreaking technologies. Big players in the pain patch industry are devising innovative technologies to fortify their standing in the market. For instance, Hisamitsu Pharmaceutical Co. Inc., a Japanese pharmaceutical corporation, unveiled the Salonpas Pain Relieving Flex Patch in June 2022. This novel pain alleviation patch comprises 4% lidocaine and utilizes thin, flexible, distinct, and highly adhesive patch technology. The patch's cloth is innovation-oriented - infused with lidocaine, the active component. The state-of-the-art patch technology facilitates maximum lidocaine prescription for ample pain relief. This pain patch is user-friendly and delivers instant pain relief.
Major companies operating in the pain patch market include:
• CVS Health Corporation
• Walgreens Boots Alliance Inc.
• Pfizer Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline plc
• Rite Aid Corporation
• Reckitt Benckiser Group plc
• Viatris Inc.
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Hikma Pharmaceuticals plc
• Endo International plc
• Amneal Pharmaceuticals LLC
• Grünenthal Group
• Allergan plc
• Hisamitsu Pharmaceutical Co. Inc.
• NICHIBAN Co. Ltd.
• Teikoku Seiyaku Co. Ltd.
• Haw Par Corporation
• Sorrento Therapeutics Inc.
• Nanjing Joyful Industrial Co. Ltd.
• NEXGEL Inc.
North America was the largest region in the pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa